Diseases [C] » Chemically-Induced Disorders [C25] » Substance-Related Disorders
Psychiatry and Psychology [F] » Mental Disorders [F03] » Substance-Related Disorders
Description
Disorders related to substance use or abuse. MeSH
Hierarchy View
Subtype Terms (15)
Alcohol-Related Disorders
35 drugs (27 approved, 8 experimental)
Amphetamine-Related Disorders
30 drugs (24 approved, 6 experimental)
Cocaine-Related Disorders
154 drugs (120 approved, 34 experimental)
Drug Overdose
13 approved drugs
Marijuana Abuse
48 drugs (39 approved, 9 experimental)
Marijuana Use
7 drugs (4 approved, 3 experimental)
Narcotic-Related Disorders
9 approved drugs
Neonatal Abstinence Syndrome
15 drugs (8 approved, 7 experimental)
Psychoses, Substance-Induced
2 approved drugs
Substance Abuse, Intravenous
10 drugs (9 approved, 1 experimental)
Substance Abuse, Oral
47 drugs (39 approved, 8 experimental)
Substance Withdrawal Syndrome
62 drugs (49 approved, 13 experimental)
Tobacco Use Disorder
92 drugs (63 approved, 29 experimental)
Phase 4 Indicated Drugs (33)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (31)
Phase 1 Indicated Drugs (52)
Other Experimental Indicated Drugs (22)
Organization Involved with Phase 4 Indications (67)
Icahn School of Medicine at Mount Sinai
Medical University of South Carolina
Member Companies of the Opioid PMR Consortium
National Institutes of Health (NIH)
Oregon Health and Science University
Stanley Medical Research Institute
State University of New York, Syracuse
The University of Texas, Dallas
Tuscaloosa Research & Education Advancement Corporation (TREAC)
Organization Involved with Phase 3 Indications (20)
French National Agency for Research on AIDS and Viral Hepatitis
Georgia Institute of Technology
Organization Involved with Phase 2 Indications (38)
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
International Center for Ethnobotanical Education, Research, and Service
Multidisciplinary Association for Psychedelic Studies
Organization Involved with Other Experimental Indications (16)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
